Klingman & Associates’s Regeneron Pharmaceuticals REGN Stock Holding History

Klingman & Associates’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell
2025 Q2	$201K	Buy
2025 Q1	–	Sell
2024 Q4	$207K	Buy
2024 Q3	$270K	Buy
2024 Q2	$266K	Buy
2024 Q1	$242K	Buy
2023 Q4	$217K	Buy
2023 Q3	$201K	Buy